Large recurrent microdeletions associated with schizophrenia (scientific article)

cites work (P2860)

Q28711804	'Sifting the significance from the data' - the impact of high-throughput genomic technologies on human genetics and health care
Q35389369	15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain.
Q37348932	15q13.3 duplication in two patients with childhood-onset schizophrenia
Q34519312	15q13.3 microdeletions increase risk of idiopathic generalized epilepsy
Q48710057	16p11.2 600 kb Duplications confer risk for typical and atypical Rolandic epilepsy.
Q37278755	1q21.1 Microduplication expression in adults
Q92229368	2018 Victor A. McKusick Leadership Award: Molecular Mechanisms for Genomic and Chromosomal Rearrangements
Q34393037	22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis
Q30478713	22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia
Q34326191	A 15q13.3 microdeletion segregating with autism
Q37354799	A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia
Q36062997	A Common CYFIP1 Variant at the 15q11.2 Disease Locus Is Associated with Structural Variation at the Language-Related Left Supramarginal Gyrus
Q35043222	A Likelihood-Based Framework for Association Analysis of Allele-Specific Copy Numbers
Q90394655	A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15
Q34957463	A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene.
Q41653839	A Mutation in NPAS3 That Segregates with Schizophrenia in a Small Family Leads to Protein Aggregation
Q51011351	A NOS1 variant implicated in cognitive performance influences evoked neural responses during a high density EEG study of early visual perception.
Q58712902	A Perspective of the Cross-Tissue Interplay of Genetics, Epigenetics, and Transcriptomics, and Their Relation to Brain Based Phenotypes in Schizophrenia
Q30986232	A Sparse Model Based Detection of Copy Number Variations From Exome Sequencing Data
Q41303299	A Statistical Method for Identifying Trait-Associated Copy Number Variants
Q90211118	A Variation in FGF14 Is Associated with Downbeat Nystagmus in a Genome-Wide Association Study
Q34104731	A co-segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder
Q39819910	A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromes
Q93191817	A comprehensive screening of copy number variability in dementia with Lewy bodies
Q29616033	A copy number variation morbidity map of developmental delay
Q37800369	A current view of Alzheimer's disease
Q35014891	A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression
Q33830989	A de novo convergence of autism genetics and molecular neuroscience
Q41927326	A de novo microdeletion in NRXN1 in a Dutch patient with mild intellectual disability, microcephaly and gonadal dysgenesis.
Q38422577	A decade of structural variants: description, history and methods to detect structural variation
Q27333802	A duplication CNV that conveys traits reciprocal to metabolic syndrome and protects against diet-induced obesity in mice and men
Q28300576	A framework for interpreting genome-wide association studies of psychiatric disorders
Q34326175	A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes
Q26860566	A genetic model for neurodevelopmental disease
Q43092679	A genome wide association analysis in the GENDER study.
Q37582988	A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation
Q50679428	A genome-wide association study of copy number variations with umbilical hernia in swine.
Q29417089	A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa
Q52687665	A genome-wide characterization of copy number variations in native populations of Peninsular Malaysia.
Q33406258	A genome-wide investigation of SNPs and CNVs in schizophrenia
Q35008897	A genome-wide investigation of copy number variation in patients with sporadic brain arteriovenous malformation
Q24644827	A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB
Q35159036	A genomic point-of-view on environmental factors influencing the human brain methylome
Q38698306	A genomic view on epilepsy and autism candidate genes
Q33727503	A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia
Q37363143	A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease
Q47569419	A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission
Q38153339	A network medicine approach to psychiatric genetics
Q38013966	A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease
Q36651496	A new role for endophenotypes in the GWAS era: functional characterization of risk variants
Q33815362	A new testing strategy to identify rare variants with either risk or protective effect on disease
Q37363081	A new wave in the genetics of psychiatric disorders: the copy number variant tsunami
Q43737132	A novel X-linked disorder with developmental delay and autistic features
Q34534743	A pilot study on collective effects of 22q13.31 deletions on gray matter concentration in schizophrenia
Q39722864	A pilot study on commonality and specificity of copy number variants in schizophrenia and bipolar disorder.
Q33839359	A population genetic approach to mapping neurological disorder genes using deep resequencing
Q34472962	A rare duplication on chromosome 16p11.2 is identified in patients with psychosis in Alzheimer's disease
Q33763087	A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay
Q37587151	A replication study of schizophrenia-related rare copy number variations in a Han Southern Chinese population.
Q22241827	A review of anti-inflammatory agents for symptoms of schizophrenia
Q30502197	A scan statistic to extract causal gene clusters from case-control genome-wide rare CNV data
Q35172094	A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes
Q37189872	A stochastic inference of de novo CNV detection and association test in multiplex schizophrenia families
Q36493182	A structure-function mechanism for schizophrenia.
Q30573762	A survey of copy-number variation detection tools based on high-throughput sequencing data.
Q37782049	A three-step workflow procedure for the interpretation of array-based comparative genome hybridization results in patients with idiopathic mental retardation and congenital anomalies
Q60948838	AMPK signaling linked to the schizophrenia-associated 1q21.1 deletion is required for neuronal and sleep maintenance
Q34308513	AZFc deletions and spermatogenic failure: a population-based survey of 20,000 Y chromosomes
Q38683122	Aberrant White Matter Microstructure in Children and Adolescents With the Subtype of Prader-Willi Syndrome at High Risk for Psychosis
Q33675310	Absence of AVPR2 copy number variation in eunatremic and dysnatremic subjects in non-Hispanic Caucasian populations
Q35726686	Absence seizures with intellectual disability as a phenotype of the 15q13.3 microdeletion syndrome
Q33797878	Accuracy of CNV Detection from GWAS Data
Q33565380	Accurate distinction of pathogenic from benign CNVs in mental retardation
Q39518772	Accurate indel prediction using paired-end short reads
Q33691446	Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function
Q90252559	Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task
Q37187314	Advanced paternal age increases the risk of schizophrenia and obsessive-compulsive disorder in a Chinese Han population.
Q21144644	Advanced paternal age is associated with impaired neurocognitive outcomes during infancy and childhood
Q37667843	Advances in molecular genetics of panic disorder
Q34167342	Advances in the genetics of schizophrenia: will high-risk copy number variants be useful in clinical genetics or diagnostics?
Q36363998	Age-dependent microRNA control of synaptic plasticity in 22q11 deletion syndrome and schizophrenia
Q30458585	Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function
Q35961858	Allele-specific copy-number discovery from whole-genome and whole-exome sequencing
Q38066550	Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia
Q36083149	Alterations of social interaction through genetic and environmental manipulation of the 22q11.2 gene Sept5 in the mouse brain
Q89287109	Altered gene expression in lymphoblastoid cell lines after subculture
Q34356542	Altered social behaviours in neurexin 1α knockout mice resemble core symptoms in neurodevelopmental disorders.
Q42510410	Ameloblastic Fibro-Odontoma of the Maxilla in a Pierre-Robin Sequence Patient.
Q24619270	An arrayed human genomic library constructed in the PAC shuttle vector pJCPAC-Mam2 for genome-wide association studies and gene therapy
Q35996972	An assessment of sex bias in neurodevelopmental disorders
Q90893776	An autism-linked missense mutation in SHANK3 reveals the modularity of Shank3 function
Q51891831	An emerging 1q21.1 deletion-associated neurodevelopmental phenotype.
Q46956051	An emerging role for Wnt and GSK3 signaling pathways in schizophrenia
Q37980010	An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model.
Q35112178	An evaluation of copy number variation detection tools from whole-exome sequencing data
Q33649276	An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosis
Q34323641	An inherited small microdeletion at 15q13.3 in a patient with early-onset obsessive-compulsive disorder
Q34469246	Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2.
Q56970470	Analysis of CHRNA7 rare variants in autism spectrum disorder susceptibility
Q46015594	Analysis of Shared Haplotypes amongst Palauans Maps Loci for Psychotic Disorders to 4q28 and 5q23-q31.
Q37541157	Analysis of copy number variations at 15 schizophrenia-associated loci.
Q36275712	Analysis of copy number variations in brain DNA from patients with schizophrenia and other psychiatric disorders
Q34873753	Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample
Q57419508	Analysis of neurogranin (NRGN) in schizophrenia
Q42253625	Analysis of the DISC1 translocation partner (11q14.3) in genetic risk of schizophrenia
Q35071401	Annual Research Review: The promise of stem cell research for neuropsychiatric disorders
Q33811294	Another tool in the genome-wide association study arsenal: population-based detection of somatic gene conversion
Q39231042	Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia
Q51809341	Are we going to end up with many distinct genomic syndromes in psychiatry?
Q35593347	Assessment of copy number variation using the Illumina Infinium 1M SNP-array: a comparison of methodological approaches in the Spanish Bladder Cancer/EPICURO study
Q46144362	Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia
Q43561820	Association between copy number variants in 16p11.2 and major depressive disorder in a German case-control sample
Q37722628	Association between copy number variation losses and alcohol dependence across African American and European American ethnic groups
Q33916948	Association between genome-wide copy number variation and arsenic-induced skin lesions: a prospective study
Q36466420	Association between the 2-bp deletion polymorphism in the duplicated version of the alpha7 nicotinic receptor gene and P50 sensory gating
Q93153758	Association of Rare Copy Number Variants With Risk of Depression
Q35680372	Association of candidate genes with phenotypic traits relevant to anorexia nervosa
Q43801006	Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia
Q93196140	Association of congenital cardiovascular malformation and neuropsychiatric phenotypes with 15q11.2 (BP1-BP2) deletion in the UK Biobank
Q50542429	Association of copy number polymorphisms at the promoter and translated region of COMT with Japanese patients with schizophrenia.
Q36031616	Association of genetic variants on 15q12 with cortical thickness and cognition in schizophrenia
Q37246923	Association of the Nicotinic Receptor α7 Subunit Gene (CHRNA7) with Schizophrenia and Visual Backward Masking
Q36192989	Association study of BCL9 gene polymorphism rs583583 with schizophrenia and negative symptoms in Japanese population
Q48894770	Association study of myelin transcription factor 1-like polymorphisms with schizophrenia in Han Chinese population.
Q36217805	Association testing of copy number variants in schizophrenia and autism spectrum disorders
Q58578955	Associations between polygenic risk scores for four psychiatric illnesses and brain structure using multivariate pattern recognition
Q47583502	Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains.
Q36315335	Atypical face shape and genomic structural variants in epilepsy
Q28277283	Autism As a Disorder of High Intelligence
Q64260600	Autism and Schizophrenia-Associated CYFIP1 Regulates the Balance of Synaptic Excitation and Inhibition
Q33515390	Autism genetics: emerging data from genome-wide copy-number and single nucleotide polymorphism scans
Q39162331	Autism genetics: opportunities and challenges for clinical translation
Q38083092	Autism spectrum disorder in the genetics clinic: a review.
Q34206314	Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models
Q21261511	BAC array CGH in patients with Velocardiofacial syndrome-like features reveals genomic aberrations on chromosome region 1q21.1
Q55436093	BAMSI: a multi-cloud service for scalable distributed filtering of massive genome data.
Q28943394	BCL9 and C9orf5 are associated with negative symptoms in schizophrenia: meta-analysis of two genome-wide association studies
Q42131712	Bayesian hierarchical mixture modeling to assign copy number from a targeted CNV array
Q48323081	Behavior genetics and postgenomics.
Q38171656	Behavior genetics: past, present, future
Q46159541	CHRFAM7A copy number and 2-bp deletion polymorphisms and antisaccade performance
Q50978367	CNV Concordance in 1,097 MZ Twin Pairs.
Q36965064	CNV analysis in Chinese children of mental retardation highlights a sex differentiation in parental contribution to de novo and inherited mutational burdens
Q24603800	CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1
Q36007752	CNV analysis in the Lithuanian population
Q24632941	CNV and nervous system diseases--what's new?
Q30988364	CNV-CH: A Convex Hull Based Segmentation Approach to Detect Copy Number Variations (CNV) Using Next-Generation Sequencing Data
Q34698719	CNV-TV: a robust method to discover copy number variation from short sequencing reads
Q29308426	CNVs conferring risk of autism or schizophrenia affect cognition in controls
Q28083143	CNVs in neuropsychiatric disorders
Q37681411	CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome.
Q64968607	CYFIP1 overexpression increases fear response in mice but does not affect social or repetitive behavioral phenotypes.
Q39975506	Can epigenetics help in the discovery of therapeutics for psychiatric disorders, especially schizophrenia?
Q37983548	Can genetics inform the management of cognitive deficits in schizophrenia?
Q35370064	Can genomics help usher schizophrenia into the age of RDoC and DSM-6?
Q37259474	Candidate genes and their interactions with other genetic/environmental risk factors in the etiology of schizophrenia
Q38197348	Carbonyl stress in schizophrenia
Q52958635	Case history and genome-wide scans for copy number variants in a family with patient having 15q11.1-q11.2 duplication and 22q11.2 deletion, and schizophrenia.
Q34085418	Case-Control Genome-Wide Association Study of Attention-Deficit/Hyperactivity Disorder
Q35875021	Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene.
Q37932929	Challenges of interpreting copy number variation in syndromic and non-syndromic congenital heart defects.
Q34134692	Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia
Q24561726	Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics
Q37688994	Child and adolescent psychiatric genetics
Q26853446	Child development and molecular genetics: 14 years later
Q57735434	Chipping away at psychiatric disorders
Q37149241	Chipping away at the common epilepsies with complex genetics: the 15q13.3 microdeletion shows the way.
Q37803056	Chipping away the 'missing heritability': GIANT steps forward in the molecular elucidation of obesity - but still lots to go.
Q39127499	Chromosomal Microarrays: Understanding Genetics of Neurodevelopmental Disorders and Congenital Anomalies
Q37346451	Chromosome abnormalities, mental retardation and the search for genes in bipolar disorder and schizophrenia
Q35228294	Chromosome microarray testing for patients with congenital heart defects reveals novel disease causing loci and high diagnostic yield
Q36851578	Clan genomics and the complex architecture of human disease
Q35491261	Clinical and cognitive characteristics of children with attention-deficit hyperactivity disorder, with and without copy number variants
Q33628729	Clinical and molecular cytogenetic analyses of four families with 1q21.1 microdeletion or microduplication
Q45908246	Clinical and parental age characteristics of rare copy number variant burden in patients with schizophrenia.
Q36380279	Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era
Q42948385	Clinical utility gene card for: 15q13.3 microdeletion syndrome.
Q28477965	Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder
Q33707698	Cognition in mouse models of schizophrenia susceptibility genes
Q33837769	Coherent somatic mutation in autoimmune disease
Q33844448	Colloquium papers: Numbering the hairs on our heads: the shared challenge and promise of phenomics
Q36070647	Common DISC1 polymorphisms disrupt Wnt/GSK3β signaling and brain development
Q36946406	Common and specific liability to addiction: approaches to association studies of opioid addiction
Q39017298	Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).
Q24597954	Common genetic variation and performance on standardized cognitive tests
Q42354762	Common inversion polymorphisms and rare microdeletions at 15q13.3.
Q37412479	Common variant at 16p11.2 conferring risk of psychosis.
Q24614376	Common variants conferring risk of schizophrenia
Q37604461	Common variants in polygenic schizophrenia.
Q42702791	Comparative analysis of copy number detection by whole-genome BAC and oligonucleotide array CGH
Q37817871	Comparative genetic approaches to the evolution of human brain and behavior
Q33895253	Comparative linkage meta-analysis reveals regionally-distinct, disparate genetic architectures: application to bipolar disorder and schizophrenia
Q34634689	Comparative studies of copy number variation detection methods for next-generation sequencing technologies
Q42621990	Comparison of six statistics of genetic association regarding their ability to discriminate between causal variants and genetically linked markers
Q30400031	Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study
Q35731269	Complex human chromosomal and genomic rearrangements
Q36608885	Comprehensive analysis of schizophrenia-associated loci highlights ion channel pathways and biologically plausible candidate causal genes
Q30360356	Computational neuroanatomy of speech production.
Q35738055	Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis
Q34051160	Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia
Q37689619	Congenital Arthrogryposis: An Extension of the 15q11.2 BP1-BP2 Microdeletion Syndrome?
Q31108616	Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics
Q28752220	Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies
Q36439318	Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease
Q90575529	Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry
Q37285259	Control of cortex development by ULK4, a rare risk gene for mental disorders including schizophrenia
Q34479642	Controlled somatic and germline copy number variation in the mouse model
Q37139004	Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia
Q88584638	Copy Number Variation Disorders
Q91786736	Copy Number Variations in Adult-onset Neuropsychiatric Diseases
Q36915572	Copy Number Variations in DISC1 and DISC1-Interacting Partners in Major Mental Illness
Q31105539	Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants
Q21198881	Copy number loss of (src homology 2 domain containing)-transforming protein 2 (SHC2) gene: discordant loss in monozygotic twins and frequent loss in patients with multiple system atrophy
Q35981240	Copy number polymorphism in plant genomes
Q48367416	Copy number variants and therapeutic response to antidepressant medication in major depressive disorder.
Q37463466	Copy number variants are frequent in genetic generalized epilepsy with intellectual disability
Q35246537	Copy number variants encompassing Mendelian disease genes in a large multigenerational family segregating bipolar disorder
Q35573434	Copy number variants for schizophrenia and related psychotic disorders in Oceanic Palau: risk and transmission in extended pedigrees
Q34811896	Copy number variants in German patients with schizophrenia
Q42249306	Copy number variants in a sample of patients with psychotic disorders: is standard screening relevant for actual clinical practice?
Q33680420	Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus
Q28304430	Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications
Q50309794	Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems.
Q37831223	Copy number variants: a new molecular frontier in clinical psychiatry
Q24651868	Copy number variation and schizophrenia
Q24642330	Copy number variation at 1q21.1 associated with neuroblastoma
Q30439224	Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders
Q34078403	Copy number variation at chromosome 5q21.2 is associated with intraocular pressure
Q34069542	Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion
Q50658828	Copy number variation distribution in six monozygotic twin pairs discordant for schizophrenia.
Q34019142	Copy number variation in human health, disease, and evolution
Q33526497	Copy number variation in the genomes of twelve natural isolates of Caenorhabditis elegans
Q34043652	Copy number variation of the SELENBP1 gene in schizophrenia
Q83179024	Copy number variation showers in schizophrenia: an emerging hypothesis
Q37642520	Copy number variations and cancer susceptibility
Q37089619	Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome
Q48526031	Copy number variations and susceptibility to lateral temporal epilepsy: a study of 21 pedigrees.
Q33833588	Copy number variations are a rare cause of non-CMT1A Charcot-Marie-Tooth disease
Q50302375	Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders.
Q36218586	Copy number variations in 6q14.1 and 5q13.2 are associated with alcohol dependence
Q36170339	Copy number variations in Saudi family with intellectual disability and epilepsy
Q34575267	Copy number variations in alternative splicing gene networks impact lifespan
Q35809326	Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease
Q35900760	Copy number variations of chromosome 16p13.1 region associated with schizophrenia
Q33361975	Copy number variations play important roles in heredity of common diseases: a novel method to calculate heritability of a polymorphism
Q34060410	Copy variations in schizophrenia and bipolar disorder
Q36451480	Copy-number disorders are a common cause of congenital kidney malformations
Q22251090	Copy-number variations associated with neuropsychiatric conditions
Q33766621	Cross-domain neurobiology data integration and exploration
Q37986834	Current understanding of human genetics and genetic analysis of psoriasis
Q92825070	Cyfip1 Haploinsufficiency Does Not Alter GABAA Receptor δ-Subunit Expression and Tonic Inhibition in Dentate Gyrus PV+ Interneurons and Granule Cells
Q28566588	Cyfip1 Regulates Presynaptic Activity during Development
Q36022165	DELISHUS: an efficient and exact algorithm for genome-wide detection of deletion polymorphism in autism
Q43015032	DISC1 as a genetic risk factor for schizophrenia and related major mental illness: response to Sullivan
Q34154488	DISC1 in schizophrenia: genetic mouse models and human genomic imaging
Q36485741	DNA methylation in a Scottish family multiply affected by bipolar disorder and major depressive disorder
Q36632924	DNA methylation in schizophrenia: progress and challenges of epigenetic studies
Q35999462	DNA sequencing: clinical applications of new DNA sequencing technologies.
Q22337096	DUF1220 domains, cognitive disease, and human brain evolution
Q33398247	De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.
Q37353964	De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot
Q36632942	De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention
Q33650848	De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability
Q24621518	De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia
Q34239141	De novo rates and selection of large copy number variation
Q37361140	Decanalization and the origin of complex disease
Q42130079	Definition and refinement of the 7q36.3 duplication region associated with schizophrenia.
Q28481601	Deleterious GRM1 mutations in schizophrenia
Q33740241	Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia
Q52307028	Deletion of 15q11.2(BP1-BP2) region: further evidence for lack of phenotypic specificity in a pediatric population.
Q37703015	Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders
Q83680991	Designing a simple multiplex ligation-dependent probe amplification (MLPA) assay for rapid detection of copy number variants in the genome
Q30885441	Detecting copy-number variations in whole-exome sequencing data using the eXome Hidden Markov Model: an 'exome-first' approach
Q37663717	Detecting large copy number variants using exome genotyping arrays in a large Swedish schizophrenia sample.
Q58050566	Detection of Genomic Imbalances by Array-Based Comparative Genomic Hybridization in Bulgarian Patients with Autism Spectrum Disorders
Q34132810	Detection of common copy number variation with application to population clustering from next generation sequencing data
Q34563191	Detection of copy number variants reveals association of cilia genes with neural tube defects
Q34624454	Detection of copy number variation by SNP-allelotyping.
Q34356036	Detection of disease-associated deletions in case-control studies using SNP genotypes with application to rheumatoid arthritis
Q34928818	Detection of sharing by descent, long-range phasing and haplotype imputation
Q33833931	Determination of beta-defensin genomic copy number in different populations: A comparison of three methods
Q37371729	Development and application of genotyping technologies
Q30477782	Development of animal models for schizophrenia
Q33581309	Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence
Q38051773	Developmental psychopathology: the role of structural variation in the genome
Q37832739	Developments in schizophrenia genetics: from linkage to microchips, deletions and duplications
Q39547767	Different transcription activity of HERV-K LTR-containing and LTR-lacking genes of the KIAA1245/NBPF gene subfamily
Q34162964	Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals
Q35390572	Diminished cerebral inhibition in neonates associated with risk factors for schizophrenia: parental psychosis, maternal depression, and nicotine use.
Q24618002	Direct measure of the de novo mutation rate in autism and schizophrenia cohorts
Q34152841	Discovering tumor suppressor genes through genome-wide copy number analysis
Q36358463	Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth
Q39108424	Discovery of copy number variants by multiplex amplifiable probe hybridization (MAPH) in candidate pigmentation genes.
Q36902087	Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.
Q37956490	Disentangling the myriad genomics of complex disorders, specifically focusing on autism, epilepsy, and schizophrenia
Q97522036	Disorders Associated With Diverse, Recurrent Deletions and Duplications at 1q21.1.
Q34775497	Disorders caused by chromosome abnormalities
Q24322974	Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling
Q30448529	Disruption of Arp2/3 results in asymmetric structural plasticity of dendritic spines and progressive synaptic and behavioral abnormalities
Q24647095	Disruption of the neurexin 1 gene is associated with schizophrenia
Q43154189	Disruptive insights in psychiatry: transforming a clinical discipline
Q41768998	Distinct disorders affecting the brain share common genetic origins
Q35538457	Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder.
Q37174458	Distribution of disease-associated copy number variants across distinct disorders of cognitive development
Q33590026	Divergent structural brain abnormalities between different genetic subtypes of children with Prader-Willi syndrome
Q36945440	Diverse types of genetic variation converge on functional gene networks involved in schizophrenia
Q24600195	Diversity of human copy number variation and multicopy genes
Q34249436	Does epilepsy in multiplex autism pedigrees define a different subgroup in terms of clinical characteristics and genetic risk?
Q33729433	Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes
Q37316924	Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort.
Q42321452	Dosage sensitivity is a major determinant of human copy number variant pathogenicity
Q35345720	Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism
Q41587750	Dosage-sensitive genes in evolution and disease
Q88692014	Double hits in schizophrenia
Q34964947	Down syndrome--recent progress and future prospects
Q38177357	Drug discovery based on genetic and metabolic findings in schizophrenia
Q28084198	Drug models of schizophrenia
Q37499225	Duplication hotspots, rare genomic disorders, and common disease
Q37362339	Duplications in RB1CC1 are associated with schizophrenia; identification in large European sample sets.
Q35956878	Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia
Q36565893	Effects of Self-Rated Health and Self-Rated Economic Situation on Depressed Mood Via Life Satisfaction Among Older Adults in Costa Rica
Q38440780	Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis
Q37377409	Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans
Q37964747	Emerging evidence for the role of genomic instability in male factor infertility
Q33989579	Endometriosis is associated with rare copy number variants
Q93067077	Endophenotypes in Schizophrenia: Digging Deeper to Identify Genetic Mechanisms
Q36994725	Engineering microdeletions and microduplications by targeting segmental duplications with CRISPR.
Q34482708	Epigenetic signaling in schizophrenia
Q37563075	Epigenetics, genomic mutations and cognitive function
Q92881212	Estimating the effect size of the 15Q11.2 BP1-BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice
Q33881325	Ethical challenges in genotype-driven research recruitment
Q36928804	Ethnic differentiation of copy number variation on chromosome 16p12.3 for association with obesity phenotypes in European and Chinese populations
Q36676842	Evaluating rare variants in complex disorders using next-generation sequencing
Q51370010	Evaluating rare variants under two-stage design.
Q30428422	Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia
Q53495664	Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha.
Q34192331	Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses.
Q22248085	Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia
Q33844453	Evolution in health and medicine Sackler colloquium: Genomic disorders: a window into human gene and genome evolution
Q37754018	Evolving role of MeCP2 in Rett syndrome and autism
Q42623377	Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders
Q37480047	Executive function, neural circuitry, and genetic mechanisms in schizophrenia
Q24620622	Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy
Q36152879	Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia
Q34566077	Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genes
Q29614573	Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations
Q30405748	Exome sequencing supports a de novo mutational paradigm for schizophrenia.
Q28263929	Exploring the role of copy number variants in human adaptation
Q37547308	Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery
Q57178492	Expression Analysis of CYFIP1 and CAMKK2 Genes in the Blood of Epileptic and Schizophrenic Patients
Q36170457	Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes
Q37058638	Expression analysis in a rat psychosis model identifies novel candidate genes validated in a large case-control sample of schizophrenia.
Q97424771	FMR1 locus isoforms: potential biomarker candidates in fragile X-associated tremor/ataxia syndrome (FXTAS)
Q36301683	Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance
Q36686684	Familial cosegregation of rare genetic variants with disease in complex disorders
Q35702888	Family-Based Benchmarking of Copy Number Variation Detection Software
Q37538006	Finding common susceptibility variants for complex disease: past, present and future
Q22122198	Finding the missing heritability of complex diseases
Q64079960	Fine-Scale Characterization of Genomic Structural Variation in the Human Genome Reveals Adaptive and Biomedically Relevant Hotspots
Q26830603	Following the genes: a framework for animal modeling of psychiatric disorders
Q37217009	Formation of chimeric genes by copy-number variation as a mutational mechanism in schizophrenia
Q35094193	Frequent loss of genome gap region in 4p16.3 subtelomere in early-onset type 2 diabetes mellitus
Q38296769	From Prader-Willi syndrome to psychosis: translating parent-of-origin effects into schizophrenia research
Q101390567	Full function of exon junction complex factor, Rbm8a, is critical for interneuron development
Q92535236	Functional Genomics of Epilepsy and Associated Neurodevelopmental Disorders Using Simple Animal Models: From Genes, Molecules to Brain Networks
Q34639776	Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models
Q63869207	Functional studies and rare variant screening of SLC1A1/EAAC1 in males with obsessive-compulsive disorder
Q36091184	Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome
Q30000781	Fusion of large-scale genomic knowledge and frequency data computationally prioritizes variants in epilepsy
Q30915634	G-CNV: A GPU-Based Tool for Preparing Data to Detect CNVs with Read-Depth Methods.
Q53428761	GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.
Q35046123	GWAS, cytomegalovirus infection, and schizophrenia.
Q42352511	GWAS: heritability missing in action?
Q36906575	Gender differences in CNV burden do not confound schizophrenia CNV associations.
Q50345846	Gene chips unmask cryptic diseases.
Q27010353	Gene expression profiling of the brain: pondering facts and fiction
Q56505464	Gene surveys identify schizophrenia triggers
Q28067507	Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models
Q39682696	Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia.
Q28303293	Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk
Q41986489	Genes and Small RNA Transcripts Exhibit Dosage-Dependent Expression Pattern in Maize Copy-Number Alterations.
Q37761136	Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics
Q33581609	Genetic Markers of Human Evolution Are Enriched in Schizophrenia
Q38886738	Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases
Q34162345	Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders
Q42605473	Genetic and morphological features of human iPSC-derived neurons with chromosome 15q11.2 (BP1-BP2) deletions
Q36825572	Genetic architecture of quantitative traits in mice, flies, and humans
Q38112901	Genetic architecture of reciprocal CNVs
Q33949729	Genetic architectures of psychiatric disorders: the emerging picture and its implications
Q47224735	Genetic basis of human congenital anomalies of the kidney and urinary tract
Q37953793	Genetic contributions to behavioural diversity at the gene-environment interface
Q33745742	Genetic copy number variants in sib pairs both affected with schizophrenia.
Q97905480	Genetic copy number variants, cognition and psychosis: a meta-analysis and a family study
Q34539953	Genetic copy number variation and general cognitive ability
Q54765119	Genetic counseling for susceptibility loci and neurodevelopmental disorders: the del15q11.2 as an example.
Q27027836	Genetic determinants of depression: recent findings and future directions
Q92356813	Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders
Q42179071	Genetic overlap between autism, schizophrenia and bipolar disorder
Q51054097	Genetic overlap between episodic memory deficits and schizophrenia: results from the Maudsley Twin Study.
Q34273450	Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.
Q37699386	Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder
Q33669117	Genetic research into bipolar disorder: the need for a research framework that integrates sophisticated molecular biology and clinically informed phenotype characterization
Q38344604	Genetic studies of schizophrenia: an update
Q52339753	Genetic susceptibility to neuroblastoma: current knowledge and future directions.
Q34603780	Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia
Q56888533	Genetic variation in 117 myelination-related genes in schizophrenia: Replication of association to lipid biosynthesis genes
Q26781213	Genetics and genomics of psychiatric disease
Q35237268	Genetics in schizophrenia: where are we and what next?
Q38731983	Genetics of Congenital Anomalies of the Kidney and Urinary Tract: The Current State of Play.
Q39456531	Genetics of Schizophrenia: Ready to Translate?
Q84797519	Genetics of autism spectrum disorders
Q34974394	Genetics of autism spectrum disorders.
Q35104978	Genetics of childhood obesity
Q41451951	Genetics of congenital heart disease
Q35237159	Genetics of drug dependence
Q33744854	Genetics of psychiatric disorders methods: molecular approaches
Q22252693	Genetics of psychosis; insights from views across the genome
Q33729022	Genetics of schizophrenia from a clinicial perspective.
Q38767128	Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics
Q37953135	Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research
Q35042553	Genome wide analysis of novel copy number variations duplications/deletions of different epileptic patients in Saudi Arabia
Q59355257	Genome-Wide Association Study in Vestibular Neuritis: Involvement of the Host Factor for HSV-1 Replication
Q46700790	Genome-Wide Mapping of Structural Variations Reveals a Copy Number Variant That Determines Reproductive Morphology in Cucumber.
Q35758604	Genome-Wide Study of Structural Variants in Bovine Holstein, Montbéliarde and Normande Dairy Breeds.
Q63433066	Genome-wide Burden of Rare Short Deletions Is Enriched in Major Depressive Disorder in Four Cohorts
Q36695755	Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3.
Q37414540	Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder
Q35109411	Genome-wide analysis shows increased frequency of copy number variation deletions in Dutch schizophrenia patients
Q34138007	Genome-wide approaches to schizophrenia
Q92454288	Genome-wide association analysis in West Highland White Terriers with atopic dermatitis
Q37611740	Genome-wide association analysis of copy number variation in recurrent depressive disorder.
Q24645076	Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants
Q40393210	Genome-wide association studies are coming for human infectious diseases
Q37175234	Genome-wide association studies in ADHD.
Q37422991	Genome-wide association studies--a summary for the clinical gastroenterologist
Q35001476	Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis
Q36486414	Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia
Q24628710	Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
Q30303052	Genome-wide association study of copy number variations (CNVs) with opioid dependence
Q29417051	Genome-wide association study of multiplex schizophrenia pedigrees.
Q57323019	Genome-wide association study of recurrent major depressive disorder in two European case–control cohorts
Q33932959	Genome-wide association study of schizophrenia in Japanese population
Q24630434	Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
Q40215640	Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness
Q37226294	Genome-wide association uncovers shared genetic effects among personality traits and mood states
Q35844617	Genome-wide burden of deleterious coding variants increased in schizophrenia
Q30427847	Genome-wide copy number variation analysis in extended families and unrelated individuals characterized for musical aptitude and creativity in music
Q33587483	Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies
Q35083552	Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer
Q37896620	Genome-wide investigation of rare structural variants identifies VIPR2 as a new candidate gene for schizophrenia
Q30439012	Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia
Q35977347	Genome-wide rare copy number variation screening in ulcerative colitis identifies potential susceptibility loci.
Q33906177	Genome-wide scan of copy number variation in late-onset Alzheimer's disease
Q29417060	Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci
Q46504843	Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder
Q34606096	Genomewide association studies: history, rationale, and prospects for psychiatric disorders
Q28752178	Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms
Q35201073	Genomic architecture of aggression: rare copy number variants in intermittent explosive disorder
Q35109761	Genomic copy number variation in disorders of cognitive development
Q37522738	Genomic copy number variation, human health, and disease
Q37198442	Genomic disorders ten years on.
Q28302565	Genomic duplication resulting in increased copy number of genes encoding the sister chromatid cohesion complex conveys clinical consequences distinct from Cornelia de Lange
Q33772616	Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice.
Q33408823	Genomic landscape of a three-generation pedigree segregating affective disorder
Q33354553	Genomic structural variation in psychiatric disorders
Q47555582	Genomic trade-offs: are autism and schizophrenia the steep price of the human brain?
Q37780792	Genomics and pharmacogenomics of schizophrenia
Q33937230	Genomics, intellectual disability, and autism
Q37654549	Genotype to phenotype-discovery and characterization of novel genomic disorders in a "genotype-first" era.
Q93043311	Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma
Q38479290	Global patterns of apparent copy number variation in birds revealed by cross-species comparative genomic hybridization
Q54441396	HNF1B alterations associated with congenital anomalies of the kidney and urinary tract.
Q27325468	Haploinsufficiency of Cyfip1 produces fragile X-like phenotypes in mice
Q35597451	Haplotype phasing and inheritance of copy number variants in nuclear families
Q37926253	Heredity in epilepsy: neurodevelopment, comorbidity, and the neurological trait
Q92709159	Heterozygous rare genetic variants in non-syndromic early-onset obesity
Q37578876	High frequencies of de novo CNVs in bipolar disorder and schizophrenia
Q34084054	High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy
Q37505079	High rate of disease-related copy number variations in childhood onset schizophrenia.
Q33480832	High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications.
Q92419063	Higher Gestational Choline Levels in Maternal Infection Are Protective for Infant Brain Development
Q47162671	Hippocampal Regulation of Postsynaptic Density Homer1 by Associative Learning.
Q43938609	Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder
Q38943761	Human adaptation and evolution by segmental duplication
Q34137857	Human behavioral informatics in genetic studies of neuropsychiatric disease: multivariate profile-based analysis
Q50309527	Human copy number variation and complex genetic disease.
Q37936473	Human endogenous retrovirus type W (HERV-W) in schizophrenia: a new avenue of research at the gene-environment interface
Q29614580	Human genetic variation and its contribution to complex traits
Q35635451	Hypoxia drives transient site-specific copy gain and drug-resistant gene expression.
Q74433521	Icelandic biotech feels the pinch
Q36301065	Identification and functional characterization of rare SHANK2 variants in schizophrenia
Q34267003	Identification of a CACNA2D4 deletion in late onset bipolar disorder patients and implications for the involvement of voltage-dependent calcium channels in psychiatric disorders.
Q33923615	Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia
Q37386040	Identification of functional marker proteins in the mammalian growth cone.
Q41692239	Identification of novel candidate disease genes from de novo exonic copy number variants.
Q50306233	Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype.
Q33836160	Identification of structural variation in mouse genomes
Q35616475	Identifying Human Genome-Wide CNV, LOH and UPD by Targeted Sequencing of Selected Regions
Q33474863	Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions
Q30451278	Imaging and genetics of language and cognition in pediatric epilepsy
Q37841455	Imaging genetics of schizophrenia.
Q34559752	Impact of constitutional copy number variants on biological pathway evolution
Q89339812	Impacts of variants of uncertain significance on parental perceptions of children after prenatal chromosome microarray testing
Q33829829	Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia
Q37940158	Implications of gene copy-number variation in health and diseases.
Q36114041	Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells
Q37397396	Imprinting regulates mammalian snoRNA-encoding chromatin decondensation and neuronal nucleolar size.
Q36580896	Improving detection of copy-number variation by simultaneous bias correction and read-depth segmentation
Q46401111	In silico identification of new genetic variations as potential risk factors for Alzheimer's disease in a microarray-oriented simulation
Q35537136	Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR
Q30639738	Increased LIS1 expression affects human and mouse brain development
Q59667688	Increased exonic de novo mutation rate in individuals with schizophrenia
Q30849515	Increased frequency of de novo copy number variants in congenital heart disease by integrative analysis of single nucleotide polymorphism array and exome sequence data
Q50302965	Increased paternal age and the influence on burden of genomic copy number variation in the general population.
Q35861470	Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia
Q61771019	Individuals with 22q11.2 deletion syndrome show intact prediction but reduced adaptation in responses to repeated sounds: Evidence from Bayesian mapping
Q34923975	Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders
Q34182841	Inferring haplotypes of copy number variations from high-throughput data with uncertainty
Q30540543	Inheritance model introduces differential bias in CNV calls between parents and offspring
Q39785277	Inherited balanced translocation t(9;17)(q33.2;q25.3) concomitant with a 16p13.1 duplication in a patient with schizophrenia.
Q22122172	Initial impact of the sequencing of the human genome
Q50803888	Integrated genetic and genomic approach in the SingaporeTranslational and Clinical Research in Psychosis Study: an overview.
Q91314962	Interactive effects between hemizygous 15q13.3 microdeletion and peripubertal stress on adult behavioral functions
Q41921519	Interstitial 1q21.1 Microdeletion Is Associated with Severe Skeletal Anomalies, Dysmorphic Face and Moderate Intellectual Disability
Q50312865	Intra-family phenotypic heterogeneity of 16p11.2 deletion carriers in a three-generation Chinese family.
Q35132379	Investigation of modifier genes within copy number variations in Rett syndrome
Q34429146	Investigation of the involvement of MIR185 and its target genes in the development of schizophrenia
Q37140379	Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition
Q30457731	Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing
Q37808466	Ionising radiation and genetic risks. XVI. A genome-based framework for risk estimation in the light of recent advances in genome research
Q35742294	Isochromosome 13 in a patient with childhood-onset schizophrenia, ADHD, and motor tic disorder
Q36004324	KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant
Q34959002	Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24.
Q52606417	KoVariome: Korean National Standard Reference Variome database of whole genomes with comprehensive SNV, indel, CNV, and SV analyses.
Q46544707	LINE-1 Retrotransposons in Healthy and Diseased Human Brain
Q43063737	Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese population
Q43852892	Lack of association of the 5-HT(3A) receptor with schizophrenia
Q54989953	Landscape of Conditional eQTL in Dorsolateral Prefrontal Cortex and Co-localization with Schizophrenia GWAS.
Q24623878	Large, rare chromosomal deletions associated with severe early-onset obesity
Q58462542	Letter to the Editor: Strong evidence for multiple psychosis susceptibility genes – a rejoinder to Crow
Q37084586	Levels of select PCB and PBDE congeners in human postmortem brain reveal possible environmental involvement in 15q11-q13 duplication autism spectrum disorder
Q61829441	Lifetime reproductive output over two generations in patients with psychosis and their unaffected siblings: the Uppsala 1915–1929 Birth Cohort Multigenerational Study
Q37290557	Linkage analysis of schizophrenia in African-American families
Q37166689	Linkage disequilibrium between two high-frequency deletion polymorphisms: implications for association studies involving the glutathione-S transferase (GST) genes
Q60044520	Local and global chromatin interactions are altered by large genomic deletions associated with human brain development
Q40966399	Long tandem repeats as a form of genomic copy number variation: structure and length polymorphism of a chromosome 5p repeat in control and schizophrenia populations
Q96172138	Long-read human genome sequencing and its applications
Q34700227	Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disorders.
Q24615307	Mapping copy number variation by population-scale genome sequencing
Q84866745	Mapping duplicated sequences
Q33425649	Markov Models for inferring copy number variations from genotype data on Illumina platforms
Q36193455	Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness
Q38272133	Medical conditions in autism spectrum disorders
Q34286145	Meta-analysis of 15 genome-wide linkage scans of smoking behavior
Q37274086	Meta-analysis of 32 genome-wide linkage studies of schizophrenia.
Q37992401	MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction
Q35216295	MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders
Q34394249	MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review
Q37730250	MicroRNAs in psychiatric and neurodevelopmental disorders
Q26744819	MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases
Q33736973	Microarray-based gene expression profiling and DNA copy number variation analysis of temporal fossa arachnoid cysts
Q37419604	Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders.
Q50312488	Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay.
Q36072998	Microdeletions and microduplications in patients with congenital heart disease and multiple congenital anomalies.
Q34050937	Microdeletions of 3q29 confer high risk for schizophrenia
Q24634151	Microduplications of 16p11.2 are associated with schizophrenia
Q38205899	Mind the gap: why many geneticists and psychological scientists have discrepant views about gene-environment interaction (G×E) research
Q30479819	Model organisms inform the search for the genes and developmental pathology underlying malformations of the human hindbrain
Q34540416	Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity
Q28081179	Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development
Q92338797	Modeling and Predicting Developmental Trajectories of Neuropsychiatric Dimensions Associated With Copy Number Variations
Q37055287	Modeling cognitive endophenotypes of schizophrenia in mice
Q24633007	Modelling schizophrenia using human induced pluripotent stem cells
Q50307016	Modest impact on risk for autism spectrum disorder of rare copy number variants at 15q11.2, specifically breakpoints 1 to 2.
Q47140966	Modulating Neuroinflammation to Treat Neuropsychiatric Disorders
Q37742118	Molecular diagnostics: between chips and customized medicine
Q46168265	Molecular karyotyping of patients with unexplained mental retardation by SNP arrays: a multicenter study
Q27691100	Molecular mechanisms in 22q11 deletion syndrome
Q42649179	Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility
Q47609682	Mouse Model of Chromosome 15q13.3 Microdeletion Syndrome Demonstrates Features Related to Autism Spectrum Disorder.
Q35015379	Mouse models of genomic syndromes as tools for understanding the basis of complex traits: an example with the smith-magenis and the potocki-lupski syndromes
Q29013643	Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism
Q37427373	Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia
Q30459624	Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia
Q44196200	Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia
Q37138653	NAHR-mediated copy-number variants in a clinical population: mechanistic insights into both genomic disorders and Mendelizing traits
Q51825997	NF1 microduplications: identification of seven nonrelated individuals provides further characterization of the phenotype.
Q36718684	NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
Q35237190	Nature and nurture in neuropsychiatric genetics: where do we stand?
Q34979398	Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis
Q37309811	Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome
Q45941265	Neuregulin-1 genotypes and eye movements in schizophrenia.
Q102063568	Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions
Q37832780	Neurobiology and phenotypic expression in early onset schizophrenia
Q37834929	Neurobiology of attention deficit/hyperactivity disorder
Q35659746	Neurocognition in early-onset schizophrenia and schizoaffective disorders
Q30442237	Neurodevelopment in schizophrenia: the role of the wnt pathways
Q34675943	Neurodevelopment, GABA system dysfunction, and schizophrenia
Q36417310	Neurodevelopmental model of schizophrenia: update 2012
Q38225161	Neuromodulation by acetylcholine: examples from schizophrenia and depression
Q34956275	Neuronal chromatin dynamics of imprinting in development and disease
Q37344755	Neuropsychiatric genomics in precision medicine: diagnostics, gene discovery, and translation
Q49723099	New GJA8 variants and phenotypes highlight its critical role in a broad spectrum of eye anomalies.
Q33725544	New copy number variations in schizophrenia.
Q38614141	New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings
Q37374232	New findings from genetic association studies of schizophrenia
Q35237172	New findings in the genetics of major psychoses
Q30468290	New frontiers in animal research of psychiatric illness
Q38189979	Nicotinic acetylcholine receptors in human genetic disease
Q36345854	No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?
Q46116562	No association between general cognitive ability and rare copy number variation
Q50303685	No evidence that common genetic risk variation is shared between schizophrenia and autism.
Q45928430	No evidence that rare coding variants in ZNF804A confer risk of schizophrenia.
Q39965238	No evidence that runs of homozygosity are associated with schizophrenia in an Irish genome-wide association dataset
Q34505634	Novel common copy number variation for early onset extreme obesity on chromosome 11q11 identified by a genome-wide analysis
Q38241786	Novel treatment strategies for schizophrenia from improved understanding of genetic risk
Q50209842	OTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion Syndrome.
Q37474789	Ohnologs are overrepresented in pathogenic copy number mutations
Q34953729	Olfactory copy number association with age at onset of Alzheimer disease
Q37894742	Oligonucleotide microarrays in constitutional genetic diagnosis
Q34085510	On the analysis of sequence data: testing for disease susceptibility loci using patterns of linkage disequilibrium
Q38215322	One gene, many neuropsychiatric disorders: lessons from Mendelian diseases.
Q55115610	Opposing phenotypes in mice with Smith-Magenis deletion and Potocki-Lupski duplication syndromes suggest gene dosage effects on fluid consumption behavior.
Q30630496	Optogenetics in psychiatric animal models
Q36899772	Ordered subset analysis of copy number variation association with age at onset of Alzheimer's disease
Q37114924	Ordered subset linkage analysis based on admixture proportion identifies new linkage evidence for alcohol dependence in African-Americans
Q30479118	Over-expression of a human chromosome 22q11.2 segment including TXNRD2, COMT and ARVCF developmentally affects incentive learning and working memory in mice
Q91554696	Overdispersed gene expression in schizophrenia
Q97531486	Overrepresentation of genetic variation in the AnkyrinG interactome is related to a range of neurodevelopmental disorders
Q38905317	Overview of the Genetics of Alcohol Use Disorder
Q33854995	Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia
Q34248252	PAIR: polymorphic Alu insertion recognition
Q92006503	Paired involvement of human-specific Olduvai domains and NOTCH2NL genes in human brain evolution
Q34572542	Palindromic GOLGA8 core duplicons promote chromosome 15q13.3 microdeletion and evolutionary instability
Q36554182	Parental origin impairment of synaptic functions and behaviors in cytoplasmic FMRP interacting protein 1 (Cyfip1) deficient mice
Q37332708	Patient participation in fundamental psychiatric genomics research: a Dutch case study
Q50303296	Penetrance for copy number variants associated with schizophrenia.
Q26852636	Perioperative genomics
Q30884325	Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint
Q29614582	Personal genomes: The case of the missing heritability
Q37768070	Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.
Q53404095	Phenotype evaluation and genomewide linkage study of clinical variables in schizophrenia.
Q35030847	Phenotype mining in CNV carriers from a population cohort
Q36498543	Phenotypic Association Analyses With Copy Number Variation in Recurrent Depressive Disorder
Q27322785	Phenotypic consequences of copy number variation: insights from Smith-Magenis and Potocki-Lupski syndrome mouse models
Q36387744	Phenotypic heterogeneity of genomic disorders and rare copy-number variants
Q34323221	Phenotypic impact of genomic structural variation: insights from and for human disease
Q37784332	Phenotypic variability and genetic susceptibility to genomic disorders
Q57419525	Phenotypic variations on the theme of CNVs
Q56806254	Pilot Study on Schizophrenia in Sardinia
Q37877244	Planning a genome-wide association study: points to consider
Q37156109	Population analysis of large copy number variants and hotspots of human genetic disease
Q30844540	Population clustering based on copy number variations detected from next generation sequencing data
Q33698577	Population-based study of genetic variation in individuals with autism spectrum disorders from Croatia
Q39170724	Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius
Q33819207	Potential Value of Genomic Copy Number Variations in Schizophrenia
Q26827502	Preclinical models of antipsychotic drug action
Q40358052	Predictors of current functioning and functional decline in schizophrenia
Q27022263	Prenatal choline and the development of schizophrenia
Q37013377	Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system
Q36621065	Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects
Q33830995	Prioritization of neurodevelopmental disease genes by discovery of new mutations
Q43450643	Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank
Q33955043	Progranulin (GRN) in two siblings of a Latino family and in other patients with schizophrenia
Q34537519	Progress and promise of genome-wide association studies for human complex trait genetics
Q37906804	Progress in defining the biological causes of schizophrenia
Q38644092	Progress in genome-wide association studies of schizophrenia in Han Chinese populations
Q38068612	Progress in imaging the effects of psychosis susceptibility gene variants
Q46170366	Progress in locating the genetic causes of schizophrenia
Q36076926	Properties and power of the Drosophila Synthetic Population Resource for the routine dissection of complex traits.
Q33399605	Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes
Q42627794	Psychiatric family history and schizophrenia risk in Denmark: which mental disorders are relevant?
Q47557531	Psychiatric genetics and the structure of psychopathology.
Q51872998	Psychiatric genetics gets a boost.
Q37159630	Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses
Q28576146	Quaking regulates Hnrnpa1 expression through its 3' UTR in oligodendrocyte precursor cells
Q34973122	RECONSTRUCTING DNA COPY NUMBER BY PENALIZED ESTIMATION AND IMPUTATION.
Q37765631	REVIEW: Genome-wide findings in schizophrenia and the role of gene-environment interplay.
Q34018852	RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders
Q35081115	Random or stochastic monoallelic expressed genes are enriched for neurodevelopmental disorder candidate genes.
Q36770065	Rare CNVs and tag SNPs at 15q11.2 are associated with schizophrenia in the Han Chinese population
Q35533255	Rare and common variants: twenty arguments
Q38245817	Rare and low-frequency variants in human common diseases and other complex traits
Q34247422	Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis
Q22337245	Rare chromosomal deletions and duplications increase risk of schizophrenia
Q35632675	Rare copy number variants are an important cause of epileptic encephalopathies
Q47236320	Rare copy number variants in neuropsychiatric disorders: Specific phenotype or not?
Q35764564	Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism
Q35764622	Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia
Q33922682	Rare copy number variation in treatment-resistant major depressive disorder
Q33707696	Rare damaging variants in DNA repair and cell cycle pathways are associated with hippocampal and cognitive dysfunction: a combined genetic imaging study in first-episode treatment-naive patients with schizophrenia
Q41768169	Rare de novo germline copy-number variation in testicular cancer
Q33847202	Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes
Q45796187	Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures
Q24605530	Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes
Q35956872	Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders
Q28607995	Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals
Q29614955	Rare variants create synthetic genome-wide associations
Q46601084	Reaching a CNV milestone
Q35749660	Read clouds uncover variation in complex regions of the human genome
Q64963710	Recent Advances in the Genetics of Schizophrenia.
Q41968850	Recent advances in the genetics of rheumatoid arthritis
Q37927126	Recent genomic advances in schizophrenia
Q64088959	Reciprocal White Matter Changes Associated With Copy Number Variation at 15q11.2 BP1-BP2: A Diffusion Tensor Imaging Study
Q37337299	Reciprocal duplication of the Williams-Beuren syndrome deletion on chromosome 7q11.23 is associated with schizophrenia
Q34381772	Reconstructing DNA copy number by joint segmentation of multiple sequences
Q39448846	Recurrent 15q11.2 BP1-BP2 microdeletions and microduplications in the etiology of neurodevelopmental disorders
Q50302372	Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity.
Q36923834	Recurrent CNVs disrupt three candidate genes in schizophrenia patients
Q38616673	Recurrent copy number variations as risk factors for neurodevelopmental disorders: critical overview and analysis of clinical implications
Q47125495	Recurrent de novo mutations in neurodevelopmental disorders: properties and clinical implications.
Q33569995	Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies
Q24629022	Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation
Q24655755	Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes
Q29544005	Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size
Q24647145	Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities
Q34004330	Reduced CHRNA7 expression in C3H mice is associated with increases in hippocampal parvalbumin and glutamate decarboxylase-67 (GAD67) as well as altered levels of GABA(A) receptor subunits
Q36519585	Reduced CYFIP1 in Human Neural Progenitors Results in Dysregulation of Schizophrenia and Epilepsy Gene Networks
Q50309743	Reduced burden of very large and rare CNVs in bipolar affective disorder.
Q91942578	Regulation and Function of Activity-Dependent Homer in Synaptic Plasticity
Q36145999	Regulatory domain or CpG site variation in SLC12A5, encoding the chloride transporter KCC2, in human autism and schizophrenia
Q34079175	Relative burden of large CNVs on a range of neurodevelopmental phenotypes
Q51140454	Replication analyses of four chromosomal deletions with schizophrenia via independent large-scale meta-analyses.
Q34434004	Research review: Polygenic methods and their application to psychiatric traits
Q35898713	Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility
Q37728113	Rethinking the genetic architecture of schizophrenia.
Q34188749	Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior
Q60435307	Review of the 6th symposium for the search for the causes of schizophrenia, Sao Paulo, Brazil, 3–6 February 2009
Q38926127	Risk alleles of genes with monoallelic expression are enriched in gain-of-function variants and depleted in loss-of-function variants for neurodevelopmental disorders
Q34580821	Robust Detection and Identification of Sparse Segments in Ultra-High Dimensional Data Analysis
Q96953395	Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?
Q37298164	SCRIB and PUF60 are primary drivers of the multisystemic phenotypes of the 8q24.3 copy-number variant
Q39705556	SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution
Q37936087	SNP array analysis in constitutional and cancer genome diagnostics--copy number variants, genotyping and quality control
Q39566363	SZDB: A Database for Schizophrenia Genetic Research
Q30717096	Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism
Q55868331	Schizophrenia
Q64070812	Schizophrenia and Hereditary Polyneuropathy: Deletion as a Common Pathophysiological Link?
Q39880626	Schizophrenia at a genetics crossroads: where to now?
Q42325307	Schizophrenia copy number variants and associative learning
Q36551460	Schizophrenia genetic variants are not associated with intelligence
Q37483078	Schizophrenia genetics: new insights from new approaches
Q37997954	Schizophrenia genetics: putting all the pieces together
Q34830762	Schizophrenia genetics: where next?
Q24595592	Schizophrenia is associated with an increase in cortical microRNA biogenesis
Q30468813	Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo
Q28727394	Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse
Q59096804	Schizophrenia: Incriminating genomic evidence
Q59117302	Schizophrenia: The Epidemiological Horizon
Q42822329	Schizophrenia: The drug deadlock
Q37461052	Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers
Q43258034	Schizophrenia: the "BLOC" may be in the endosomes
Q57807080	Screening of congenital heart disease patients using multiplex ligation-dependent probe amplification: Early diagnosis of syndromic patients
Q33611367	Search for copy number variants in chromosomes 15q11-q13 and 22q11.2 in obsessive compulsive disorder
Q48234429	Searching for new genetic risk factors for neuropsychiatric disorders in expression databases
Q39989454	Searching for the true genetic vulnerability for schizophrenia
Q37559492	Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future
Q50764053	Segmental copy number loss in the region of Semaphorin 4D gene in patients with acetabular dysplasia.
Q50345700	Sequence analysis of 17 NRXN1 deletions.
Q37217642	Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion
Q50034912	Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap.
Q40043984	Shifting the focus toward rare variants in schizophrenia to close the gap from genotype to phenotype.
Q31158031	Simultaneous copy number losses within multiple subtelomeric regions in early-onset type 2 diabetes mellitus
Q37326513	Singleton deletions throughout the genome increase risk of bipolar disorder
Q37021707	Social cognition in 22q11.2 microdeletion syndrome: relevance to psychosis?
Q37501275	Somatic deletions implicated in functional diversity of brain cells of individuals with schizophrenia and unaffected controls
Q37487752	Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network
Q42164701	Spatiotemporal 16p11.2 protein network implicates cortical late mid-fetal brain development and KCTD13-Cul3-RhoA pathway in psychiatric diseases
Q37601955	Statistical issues in the analysis of DNA Copy Number Variations
Q39202144	Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder
Q24630444	Strong synaptic transmission impact by copy number variations in schizophrenia
Q33811233	Structural variation in the chicken genome identified by paired-end next-generation DNA sequencing of reduced representation libraries.
Q27691419	Structural variation mutagenesis of the human genome: Impact on disease and evolution
Q24308919	Structure and control of the actin regulatory WAVE complex
Q28283600	Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological?
Q33691327	Studies on the hippocampal formation: From basic development to clinical applications: Studies on schizophrenia
Q35542036	Study designs for identification of rare disease variants in complex diseases: the utility of family-based designs
Q47394958	Subchronic olanzapine exposure leads to increased expression of myelination-related genes in rat fronto-medial cortex.
Q37147142	Support for the involvement of large copy number variants in the pathogenesis of schizophrenia
Q37444933	Synaptic Actin Dysregulation, a Convergent Mechanism of Mental Disorders?
Q58762401	Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models
Q33803707	Synthetic associations created by rare variants do not explain most GWAS results
Q34329016	Systematic genotype-phenotype analysis of autism susceptibility loci implicates additional symptoms to co-occur with autism
Q34323019	Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes
Q36456196	Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study
Q48756991	Tau's role in the developing brain: implications for intellectual disability.
Q92734934	Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia
Q42720402	The 1000 Genomes Project: deep genomic sequencing waiting for deep psychiatric phenotyping
Q28081580	The 15q11.2 BP1-BP2 microdeletion syndrome: a review
Q30468033	The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders
Q42748361	The 3q29 deletion confers >40-fold increase in risk for schizophrenia
Q48235670	The Clinical Utility of a Single-Nucleotide Polymorphism Microarray in Patients With Epilepsy at a Tertiary Medical Center
Q37239901	The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta-analysis across different European populations
Q28658990	The Danish 22q11 research initiative
Q28685216	The Growing Importance of CNVs: New Insights for Detection and Clinical Interpretation
Q22241683	The Kraepelinian dichotomy - going, going... but still not gone
Q59812449	The Role of the Eukaryotic Translation Initiation Factor 4E (eIF4E) in Neuropsychiatric Disorders
Q35018781	The association between intelligence scores and family history of psychiatric disorder in schizophrenia patients, their siblings and healthy controls
Q28572147	The autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of dendritic complexity and the stabilization of mature spines
Q92353062	The autism- and schizophrenia-associated protein CYFIP1 regulates bilateral brain connectivity and behaviour
Q24308763	The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function
Q37704614	The clinical context of copy number variation in the human genome
Q35547325	The contribution of genetic variants to disease depends on the ruler
Q90712113	The copy number variation landscape of congenital anomalies of the kidney and urinary tract
Q22242827	The dopamine hypothesis of schizophrenia: version III--the final common pathway
Q91779468	The dynamics of disordered dialogue: Prefrontal, hippocampal and thalamic miscommunication underlying working memory deficits in schizophrenia
Q33786964	The effect of algorithms on copy number variant detection
Q34714815	The effects of aging vs. α7 nAChR subunit deficiency on the mouse brain transcriptome: aging beats the deficiency
Q37578863	The emerging role of genomics in the diagnosis and workup of congenital urinary tract defects: a novel deletion syndrome on chromosome 3q13.31-22.1.
Q38006632	The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants
Q30386814	The exon junction complex in neural development and neurodevelopmental disease.
Q37079514	The genetic architecture of methotrexate toxicity is similar in Drosophila melanogaster and humans
Q24607129	The genetic basis of addictive disorders
Q34283901	The genetic basis of non-syndromic intellectual disability: a review
Q38151716	The genetic landscape of autism spectrum disorders
Q33965270	The genetic variability and commonality of neurodevelopmental disease
Q35007575	The genetics of Tourette disorder
Q35012899	The genetics of Tourette syndrome: a review.
Q37390402	The genetics of childhood-onset schizophrenia: when madness strikes the prepubescent
Q35765523	The genetics of microdeletion and microduplication syndromes: an update.
Q30429472	The genome-wide landscape of copy number variations in the MUSGEN study provides evidence for a founder effect in the isolated Finnish population
Q37059547	The genomic psychiatry cohort: partners in discovery
Q36799509	The genomically mosaic brain: aneuploidy and more in neural diversity and disease
Q34381708	The genomics of schizophrenia: update and implications.
Q26821785	The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function
Q36144791	The human clinical phenotypes of altered CHRNA7 copy number
Q37583679	The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation
Q36931989	The human imprintome: regulatory mechanisms, methods of ascertainment, and roles in disease susceptibility
Q34279459	The hunt for gene effects pertinent to behavioral traits and psychiatric disorders: from mouse to human
Q38231949	The hypocretin/orexin system: an increasingly important role in neuropsychiatry.
Q50308309	The impact of chromosomal microarray on clinical management: a retrospective analysis.
Q34241597	The impact of errors in copy number variation detection algorithms on association results
Q38682213	The impact of genetics on future drug discovery in schizophrenia
Q37682292	The impact of human copy number variation on a new era of genetic testing.
Q52355396	The integrated landscape of causal genes and pathways in schizophrenia.
Q34026930	The landscape of inherited and de novo copy number variants in a Plasmodium falciparum genetic cross
Q60920667	The many roads to psychosis: recent advances in understanding risk and mechanisms
Q34497136	The penetrance of copy number variations for schizophrenia and developmental delay.
Q34694730	The phenotype of recurrent 10q22q23 deletions and duplications
Q96302720	The polygenic architecture of schizophrenia - rethinking pathogenesis and nosology
Q37294982	The presence of two rare genomic syndromes, 1q21 deletion and Xq28 duplication, segregating independently in a family with intellectual disability
Q30471071	The presynaptic component of the serotonergic system is required for clozapine's efficacy.
Q37445023	The prevalence of chromosomal deletions relating to developmental delay and/or intellectual disability in human euploid blastocysts
Q36213630	The psoriasis-associated deletion of late cornified envelope genes LCE3B and LCE3C has been maintained under balancing selection since Human Denisovan divergence.
Q44876377	The road less traveled: from genotype to phenotype in flies and humans.
Q37658896	The role of copy number variation in schizophrenia
Q90728372	The role of genetics and genomics in clinical psychiatry
Q28748800	The role of genetics in the etiology of schizophrenia
Q38910344	The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions
Q22241409	The shock of the new: progress in schizophrenia genomics
Q33626171	The translationally relevant mouse model of the 15q13.3 microdeletion syndrome reveals deficits in neuronal spike firing matching clinical neurophysiological biomarkers seen in schizophrenia.
Q38113668	The unexpected role of copy number variations in juvenile myoclonic epilepsy
Q38718345	Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries
Q33409947	Tissue-specific genetic control of splicing: implications for the study of complex traits
Q45421412	Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia
Q35604900	Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).
Q35705783	Transcriptome Profiling of Peripheral Blood in 22q11.2 Deletion Syndrome Reveals Functional Pathways Related to Psychosis and Autism Spectrum Disorder
Q35882608	Transcriptome outlier analysis implicates schizophrenia susceptibility genes and enriches putatively functional rare genetic variants
Q57697189	Transcriptomic signatures of schizophrenia revealed by dopamine perturbation in an ex vivo model
Q34991710	Translational disease interpretation with molecular networks.
Q34220141	Translational neuroscience of schizophrenia: seeking a meeting of minds between mouse and man.
Q28771512	Transmembrane protein 108 is required for glutamatergic transmission in dentate gyrus
Q37356489	Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis
Q33960019	Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia
Q27004669	Two patients walk into a clinic...a genomics perspective on the future of schizophrenia
Q37308665	Type 2 diabetes: new genes, new understanding
Q33353558	Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's disease
Q37274686	Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome
Q37755970	Uncovering the roles of rare variants in common disease through whole-genome sequencing
Q47702394	Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons
Q34916111	Understanding the genetics of behavioural and psychiatric traits will only be achieved through a realistic assessment of their complexity
Q21202865	Understanding the impact of 1q21.1 copy number variant
Q50535284	Unique Molecular Regulation of Higher-Order Prefrontal Cortical Circuits: Insights into the Neurobiology of Schizophrenia.
Q30241067	Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders
Q28572188	Up-regulated cytoplasmic FMRP-interacting protein 1 in intractable temporal lobe epilepsy patients and a rat model
Q37440313	Update on the genetics of stroke and cerebrovascular disease 2008.
Q38202490	Use of RNA interference by in utero electroporation to study cortical development: the example of the doublecortin superfamily
Q58075316	Use of Register Data for Psychiatric Epidemiology in the Nordic Countries
Q24604693	Using ERDS to infer copy-number variants in high-coverage genomes
Q30808425	Using XHMM Software to Detect Copy Number Variation in Whole-Exome Sequencing Data
Q38637625	Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms
Q36332602	Using human brain imaging studies as a guide toward animal models of schizophrenia.
Q50418525	Using mouse transgenic and human stem cell technologies to model genetic mutations associated with schizophrenia and autism.
Q36003093	Using multivariate machine learning methods and structural MRI to classify childhood onset schizophrenia and healthy controls
Q36932681	Using population admixture to help complete maps of the human genome
Q37642319	VTET: a variable threshold exact test for identifying disease-associated copy number variations enriched in short genomic regions
Q43510887	Variants in the 1q21 risk region are associated with a visual endophenotype of autism and schizophrenia.
Q33641952	Visualization and probability-based scoring of structural variants within repetitive sequences
Q37612075	What have the genomics ever done for the psychoses?
Q42132685	What is complex about complex disorders?
Q82255345	What price personal genome exploration?
Q38670598	When genotype is not predictive of phenotype: implications for genetic counseling based on 21,594 chromosomal microarray analysis examinations
Q37725879	Whole genome association studies in complex diseases: where do we stand?
Q36626867	Whole-genome detection of disease-associated deletions or excess homozygosity in a case-control study of rheumatoid arthritis
Q39554597	Whole-genome resequencing of 292 pigeonpea accessions identifies genomic regions associated with domestication and agronomic traits
Q53297737	[Implication of human endogenous retroviruses in schizophrenia and bipolar disorder].
Q50975311	[Schizophrenia, genetics and cognition].
Q52674973	[Search for risk genes in schizophrenia].
Q38374419	eHealth provides a novel opportunity to exploit the advantages of the Nordic countries in psychiatric genetic research, building on the public health care system, biobanks, and registries
Q42976183	β-catenin promoter ChIP-chip reveals potential schizophrenia and bipolar disorder gene network

P6179	Dimensions Publication ID	1038869319
P356	DOI	10.1038/NATURE07229
P3181	OpenCitations bibliographic resource ID	379835
P932	PMC publication ID	2687075
P698	PubMed publication ID	18668039
P5875	ResearchGate publication ID	23138435

P50	author	David B. Goldstein	Q15989762
		Marcella Rietschel	Q20742720
		Evangelos Vassos	Q21094949
		Hans-Jürgen Möller	Q1577771
		Leena Peltonen-Palotie	Q2399315
		Kári Stefánsson	Q6453246
		Robin Murray	Q7352679
		David Collier	Q21094975
		Sven Cichon	Q28050103
		Dan Rujescu	Q28050107
		Augustine Kong	Q28050134
		Hreinn Stefansson	Q28050141
		Unnur Þorsteinsdóttir	Q28050158
		Thomas Werge	Q29122092
		Jes Olesen	Q29643374
		Andrés Ingason	Q114270588
		Olli P H Pietiläinen	Q114270893
		Ragnheidur Fossdal	Q114366499
		Timi Toulopoulou	Q114366501
		Kevin V Shianna	Q114366502
		Arnaldur Gylfason	Q114366504
		Caroline Crombie	Q114366505
		Jacobine E Buizer-Voskamp	Q114366506
		Asgeir Bjornsson	Q114515798
		Dongliang Ge	Q115248929
		Jouko Lönnqvist	Q29840812
		Anna C. Need	Q30347446
		Daníel F. Guðbjartsson	Q30348313
		Barbara Franke	Q30388929
		Aslaug Jonasdottir	Q30434719
		Ole A. Andreassen	Q31229142
		Srdjan Djurovic	Q34568432
		Markus M Nöthen	Q37634364
		Thomas F. Hansen	Q37651587
		Richard Bruggeman	Q37652571
		Adalbjorg Jonasdottir	Q38154259
		Jaana Suvisaari	Q39998334
		Lambertus Kiemeney	Q40024880
		Henrik Ullum	Q40974711
		Clyde Francks	Q42305970
		Muriel Walshe	Q42305977
		Engilbert Sigurdsson	Q43301079
		Thordur Sigmundsson	Q43302977
		Paul M. Matthews	Q43864655
		Alexander Georgi	Q46482741
		Marta Di Forti	Q46888593
		Ingrid Melle	Q47083123
		Tiina Paunio	Q47405528
		Thorgeir E. Thorgeirsson	Q47502252
		Bjarni V. Halldórsson	Q47502536
		Elvira Bramon	Q52013079
		Roel Ophoff	Q58911354
		Gillian M Fraser	Q64683218
		Jeffrey Gulcher	Q66823431
		Nelson A. Freimer	Q67465306
		Ina Giegling	Q79440178
		Thomas W Mühleisen	Q87871468
		Sarah Tosato	Q87889193
		Asgeir Sigurdsson	Q88734369
		Stacy Steinberg	Q89583861
		David St Clair	Q89918892
		Pierandrea Muglia	Q89919709
		Brynja Magnusdottir	Q90090042
		Mirella Ruggeri	Q91764571
		Annette M Hartmann	Q92100086
		Cătălina-Andreea Vasilescu	Q108704680
P2093	author name string	Tao Li
		Chiara Sabatti
		Hannes Petursson
		Nicholas Walker
		Thorarinn Blondal
		August G Wang
		Klaus D Jakobsen
		Magnus Haraldsson
		Annamarie Tuulio-Henriksson
		Sigurborg Mattiasdottir
P2860	cites work	Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women	Q21145218
		Rare chromosomal deletions and duplications increase risk of schizophrenia	Q22337245
		Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23	Q24536215
		Connexin 50 gene on human chromosome 1q21 is associated with schizophrenia in matched case control and family-based studies	Q24648392
		Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22	Q28143069
		Disruption of two novel genes by a translocation co-segregating with schizophrenia	Q28144559
		A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders	Q28262802
		Association between microdeletion and microduplication at 16p11.2 and autism	Q28264205
		Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia	Q28274064
		Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory	Q28588757
		Presynaptic type III neuregulin1-ErbB signaling targets {alpha}7 nicotinic acetylcholine receptors to axons	Q28593522
		The female and the fragile X syndrome: data on clinical and psychological findings in 7 fra(X) carriers	Q30610480
		Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases	Q30830662
		QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data	Q31104515
		Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11.	Q33992163
		Diagnostic genome profiling in mental retardation	Q34114527
		Schizophrenia and velo-cardio-facial syndrome.	Q34530657
		Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome	Q34556894
		Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus	Q35956504
		Fertility and sibship size in a psychiatric patient population. A comparison with national census data	Q36555528
		Autistic-like symptomatology in Prader-Willi syndrome: a review of recent findings	Q36772023
		The Prader-Willi phenotype of fragile X syndrome	Q46068380
		The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders.	Q50310325
		Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment.	Q51907423
		Characterization of a 5.3 Mb deletion in 15q14 by comparative genomic hybridization using a whole genome "tiling path" BAC array in a girl with heart defect, cleft palate, and developmental delay.	Q51909004
		Neurobehavioral characteristics of CGG amplification status in fragile X females.	Q52021175
		Linkage of schizophrenia with chromosome 1q loci in Taiwanese families.	Q52550480
		A two-stage linkage analysis of Chinese schizophrenia pedigrees in 10 target chromosomes	Q57590010
		Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer	Q77531704
		A high-resolution survey of deletion polymorphism in the human genome	Q94465012
P433	issue	7210
P407	language of work or name	English	Q1860
P921	main subject	schizophrenia	Q41112
P304	page(s)	232-6
P577	publication date	2008-09-11
P1433	published in	Nature	Q180445
P1476	title	Large recurrent microdeletions associated with schizophrenia
P478	volume	455

Large recurrent microdeletions associated with schizophrenia

scientific article

Reverse relations